Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)UnknownNCT04672005
What this trial is testing

Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Lyudmyla Berim 30
Testing effectiveness (Phase 2)Study completedNCT00727441
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Not applicableUnknownNCT03570502
What this trial is testing

Incidence of POPF in the Resection of the Left Pancreas With RFAT

Who this might be right for
Pancreas NeoplasmPancreas CancerPancreatic Adenocarcinoma+1 more
Hospital del Mar 38
Testing effectiveness (Phase 2)Looking for participantsNCT07226856
What this trial is testing

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Mayo Clinic 43
Testing effectiveness (Phase 2)Study completedNCT01415713
What this trial is testing

The Study of Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
National Health Research Institutes, Taiwan 73
Early research (Phase 1)Not Yet RecruitingNCT06913218
What this trial is testing

MRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

Who this might be right for
Pancreas CancerPancreas Cancer, Duct Cell Adenocarcinoma
Akeso 60
Early research (Phase 1)Looking for participantsNCT07094113
What this trial is testing

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Who this might be right for
KRAS Altered Advanced or Metastatic Solid Tumors
Amgen 434
Testing effectiveness (Phase 2)Study completedNCT02080260
What this trial is testing

Regorafenib in Advanced Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Wake Forest University Health Sciences 20
Early research (Phase 1)Study completedNCT05303090
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05094336
What this trial is testing

Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Who this might be right for
Advanced MTAP-null Solid Tumors
Amgen 329
Testing effectiveness (Phase 2)Ended earlyNCT02031536
What this trial is testing

Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

Who this might be right for
GastrinomaGlucagonomaInsulinoma+4 more
ECOG-ACRIN Cancer Research Group 2
Testing effectiveness (Phase 2)Study completedNCT00112697
What this trial is testing

Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
UNICANCER 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513
What this trial is testing

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

Who this might be right for
Appendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more
M.D. Anderson Cancer Center 133
Very early researchLooking for participantsNCT07033689
What this trial is testing

Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)

Who this might be right for
Pancreatic Cancer
SONIRE Therapeutics Inc. 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07415525
What this trial is testing

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic Adenocarcinoma
Zhejiang University 40
Testing effectiveness (Phase 2)Study completedNCT02820857
What this trial is testing

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer

Who this might be right for
Neuroendocrine Carcinomas
Hospices Civils de Lyon 153
Early research (Phase 1)Not Yet RecruitingNCT07699757
What this trial is testing

HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion

Who this might be right for
Non-Small Cell Lung CancerPancreatic Ductal Adenocarcinoma (mPDAC)Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd. 258
Not applicableStudy completedNCT03834701
What this trial is testing

Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaPancreas Neoplasm+1 more
Catholic University of the Sacred Heart 60
Not applicableLooking for participantsNCT06867172
What this trial is testing

Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic SteatosisPancreatic CystPancreatic Adenocarcinoma
Carol Davila University of Medicine and Pharmacy 66
Next Page